Rituximab Biosimilars Market: Expanding Access to Targeted...

Ajouter une nouvelle offre d'emploi Wellness

2026-08-10 07:24:03 -

The Rituximab Biosimilars Market focuses on biologic products developed to closely match rituximab, an antibody-based therapy used in hematological malignancies and selected autoimmune diseases. Rituximab works by targeting CD20-positive B cells, making it valuable in conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, psoriatic arthritis, and...

0 Commentaires 0 Parts 127 Vue 0 Aperçu